In a filing, Jazz Pharmaceuticals plc revealed its SVP, Chief Accounting Officer Carr Patricia unloaded Company’s shares for reported $0.21 million on Mar 07 ’24. In the deal valued at $116.98 per share,1,768 shares were sold. As a result of this transaction, Carr Patricia now holds 6,596 shares worth roughly $0.8 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Carr Patricia sold 1,936 shares, generating $231,628 in total proceeds. Upon selling the shares at $119.64, the SVP, Chief Accounting Officer now owns 8,364 shares.
Before that, Johnson Philip L bought 12,000 shares. Jazz Pharmaceuticals plc shares valued at $1,435,800 were divested by the EVP & Chief Financial Officer at a price of $119.65 per share. As a result of the transaction, Johnson Philip L now holds 27,932 shares, worth roughly $3.4 million.
Robert W. Baird initiated its Jazz Pharmaceuticals plc [JAZZ] rating to an Outperform in a research note published on January 03, 2024; the price target was $160. A number of analysts have revised their coverage, including UBS’s analysts, who decreased its forecast for the stock in late November from “a Buy” to “a Neutral”. Raymond James began covering JAZZ with “Mkt perform” recommendation on September 29, 2023.
Price Performance Review of JAZZ
On Friday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock fall -1.85% to $121.81. Over the last five days, the stock has gained 0.75%. Jazz Pharmaceuticals plc shares have fallen nearly -0.97% since the year began. Nevertheless, the stocks have fallen -12.03% over the past one year. While a 52-week high of $147.98 was reached on 02/26/24, a 52-week low of $111.25 was recorded on 01/19/24. SMA at 50 days reached $122.40, while 200 days put it at $126.98. A total of 0.69 million shares were traded, compared to the trading of 0.68 million shares in the previous session.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 120.46, which if violated will result in even more drops to 119.10. On the upside, there is a resistance level at 124.22. A further resistance level may holdings at 126.62. The Relative Strength Index (RSI) on the 14-day chart is 49.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.71, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 39.43%. Stochastics %K at 78.17% indicates the stock is a holding.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on Feb 29, 2024, growing by 0.18 million shares to a total of 2.39 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 2.21 million shares. There was a rise of 7.53%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.42% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.4.
